Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| General Surgery | 572.2 | 487.8 | 491.8 | 412.9 | 367.4 | | 274.2 | 279.4 |
| Orthopedic Surgery | 438.4 | 374.7 | 463.3 | 446.7 | 428.9 | | 445.0 | 402.8 |
| Transferred over Time | 44.4 | 38.0 | 38.9 | 34.6 | 33.6 | | | |
| Other | | | | | | | | 57.9 |
| Total revenues | 1,010.6 | 862.5 | 955.1 | 859.6 | 796.4 | 763.5 | 719.2 | 740.1 |
| Revenue growth [+] | 17.2% | -9.7% | 11.1% | 7.9% | 4.3% | 6.2% | -2.8% | -3.0% |
| General Surgery | 17.3% | -0.8% | 19.1% | 12.4% | | | -1.8% | -2.6% |
| Orthopedic Surgery | 17.0% | -19.1% | 3.7% | 4.1% | | | 10.5% | -1.8% |
| Transferred over Time | 16.9% | -2.3% | 12.4% | 3.1% | | | | |
| Cost of goods sold | 442.6 | 402.2 | 430.4 | 390.5 | 365.4 | 355.2 | 337.5 | 336.0 |
| Gross profit | 568.0 | 460.3 | 524.7 | 469.1 | 431.0 | 408.3 | 381.7 | 404.1 |
| Gross margin | 56.2% | 53.4% | 54.9% | 54.6% | 54.1% | 53.5% | 53.1% | 54.6% |
| Selling, general and administrative | 414.8 | 373.8 | 400.1 | 355.6 | 351.8 | 338.4 | 303.1 | 323.5 |
| Research and development | 43.6 | 40.5 | 45.5 | 42.2 | 32.3 | 32.3 | 27.4 | 27.8 |
| EBITDA [+] | 180.5 | 118.6 | 151.4 | 132.1 | 104.4 | 93.0 | 95.1 | 98.5 |
| EBITDA growth | 52.1% | -21.7% | 14.7% | 26.5% | 12.3% | -2.2% | -3.5% | -5.6% |
| EBITDA margin | 17.9% | 13.8% | 15.9% | 15.4% | 13.1% | 12.2% | 13.2% | 13.3% |
| Depreciation | 37.4 | 38.4 | 40.0 | 37.6 | 36.2 | 35.3 | 31.3 | 32.7 |
| EBITA | 143.0 | 80.2 | 111.4 | 94.5 | 68.2 | 57.7 | 63.8 | 65.8 |
| EBITA margin | 14.2% | 9.3% | 11.7% | 11.0% | 8.6% | 7.6% | 8.9% | 8.9% |
| Amortization of intangibles | 33.3 | 34.2 | 32.3 | 23.2 | 21.3 | 20.0 | 12.6 | 13.0 |
| EBIT [+] | 109.7 | 46.0 | 79.1 | 71.3 | 46.9 | 37.7 | 51.2 | 52.8 |
| EBIT growth | 138.5% | -41.8% | 11.0% | 51.9% | 24.6% | -26.4% | -3.1% | -6.6% |
| EBIT margin | 10.9% | 5.3% | 8.3% | 8.3% | 5.9% | 4.9% | 7.1% | 7.1% |
| Interest expense | 35.5 | 44.1 | 42.7 | 20.7 | 18.2 | 15.4 | 6.0 | 6.1 |
| Interest expense | 35.5 | 44.1 | 42.7 | 20.7 | 18.2 | 15.4 | 6.0 | 6.1 |
| Other income (expense), net [+] | -1.1 | -0.4 | -5.2 | | | -2.9 | | |
| Other non-ooperating expenses | 1.1 | 0.4 | 5.2 | | | 2.9 | | |
| Other | -1.1 | -0.4 | -5.2 | | | -2.9 | | |
| Pre-tax income | 73.1 | 1.6 | 31.2 | 50.7 | 28.7 | 19.4 | 45.1 | 46.7 |
| Income taxes | 10.6 | -7.9 | 2.6 | 9.8 | -26.8 | 4.7 | 14.6 | 14.5 |
| Tax rate | 14.4% | | 8.3% | 19.3% | | 24.3% | 32.4% | 31.0% |
| Net income | 62.5 | 9.5 | 28.6 | 40.9 | 55.5 | 14.7 | 30.5 | 32.2 |
| Net margin | 6.2% | 1.1% | 3.0% | 4.8% | 7.0% | 1.9% | 4.2% | 4.3% |
| |
| Basic EPS [+] | $2.14 | $0.33 | $1.01 | $1.45 | $1.99 | $0.53 | $1.10 | $1.17 |
| Growth | 544.1% | -67.0% | -30.5% | -26.8% | 276.6% | -52.2% | -6.1% | -9.4% |
| Diluted EPS [+] | $1.94 | $0.32 | $0.97 | $1.41 | $1.97 | $0.52 | $1.09 | $1.16 |
| Growth | 501.0% | -66.7% | -31.4% | -28.2% | 275.6% | -52.1% | -5.6% | -9.3% |
| |
| Dividends per share [+] | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 |
| Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 23.1% |
| |
| Shares outstanding (basic) [+] | 29.2 | 28.6 | 28.3 | 28.1 | 27.9 | 27.8 | 27.7 | 27.4 |
| Growth | 2.0% | 0.9% | 0.7% | 0.6% | 0.5% | 0.5% | 0.9% | -1.2% |
| Shares outstanding (diluted) [+] | 32.2 | 29.5 | 29.5 | 28.9 | 28.2 | 28.0 | 27.9 | 27.8 |
| Growth | 9.3% | -0.1% | 2.1% | 2.6% | 0.7% | 0.4% | 0.3% | -1.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|